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Abstract
Telomeric and subtelomeric regions of human chromosomes largely consist of highly repetitive and redundant DNA
sequences, resulting in a paucity of unique DNA sequences specific to individual telomeres. Accordingly, it is difficult to
analyze telomere metabolism on a single-telomere basis. To circumvent this problem, we have exploited a human artificial
chromosome (HAC#21) derived from human chromosome 21 (hChr21). HAC#21 was generated through truncation of the
long arm of native hChr21 by the targeted telomere seeding technique. The newly established telomere of HAC#21 lacks
canonical subtelomere structures but possesses unique sequences derived from the target vector backbone and the
internal region of hChr21 used for telomere targeting, which enabled us to molecularly characterize the single HAC
telomere. We established HeLa and NIH-3T3 sub-lines containing a single copy of HAC#21, where it was robustly
maintained. The seeded telomere is associated with telomeric proteins over a length similar to that reported in native
telomeres, and is faithfully replicated in mid-S phase in HeLa cells. We found that the seeded telomere on HAC#21 is
transcribed from the newly juxtaposed site. The transcript, HAC-telRNA, shares several features with TERRA (telomeric
repeat-containing RNA): it is a short-lived RNA polymerase II transcript, rarely contains a poly(A) tail, and associates with
chromatin. Interestingly, HAC-telRNA undergoes splicing. These results suggest that transcription into TERRA is locally
influenced by the subtelomeric context. Taken together, we have established human and mouse cell lines that will be useful
for analyzing the behavior of a uniquely identifiable, functional telomere.
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Introduction
The telomere nucleoprotein complex protects linear chromo-
somal ends from degradation and fusion in eukaryotes. Telomere
DNA is composed of a duplex array of 59-TTAGGG-39/59-
CCCTAA-39 that runs from a few to a hundred kilobases (kb) in
mammals. The guanine-rich strand (TTAGGG repeats) and the
cytosine-rich strand (CCCTAA repeats) are called the G-strand
and C-strand, respectively. A terminal 50 to 200-nt stretch of the
G-strand protrudes from the 39-end of the chromosome as single-
stranded DNA (G-tail). Telomere repeats recruit a six-protein
complex called shelterin, consisting of TRF1, TRF2, Rap1, TIN2,
TPP1, and POT1 [1]. Of these, TRF1 and TRF2 directly bind to
the double-stranded (ds) telomere repeat DNA, and POT1 binds
to the single-stranded (ss) G-tail. Shelterin plays a pivotal role in
maintaining telomere integrity. First, it prevents telomeres from
eliciting a DNA damage response and activating DNA repair that
would otherwise lead to mitotically catastrophic end-to-end fusions
[2,3]. Second, it has been recently revealed that TPP1 recruits
telomerase, a specialized reverse transcriptase that counteracts
replication-dependent shortening of telomeres [4,5]. Paradoxical-
ly, telomeres must protect themselves, presumably by barring
access to trans-factors such as DNA damage checkpoint sensors
and DNA repair enzymes, yet telomeres must accommodate trans-
factors necessary for maintaining telomere integrity, such as the
DNA replication apparatus. Therefore, it is supposed that
telomeres dynamically change their structure and function during
the cell cycle, differentiation, and ageing. From this perspective, it
is important to understand when and how telomeres are replicated
in S phase.
Telomere DNAs as a whole are replicated throughout S phase
[6,7]. However, individual telomeres are replicated at different
and specific time-windows in S phase [8,9]. We previously
measured the replication timing of one seeded telomere in HeLa
cells, and found that the particular single telomere is replicated in
a 4-hr interval peaking at 4 hr post-release of the G1/S cell cycle
block [10].
Telomere DNA is transcribed by RNA polymerase II (Pol II) to
produce a non-coding telomeric repeat-containing RNA (TERRA)
initiating from subtelomeric regions to G-strands in a wide range
of species [11,12]. Some TERRAs are generated from a single
transcription start site 1–2 kb proximal to the telomere repeats
[13]. A specific CpG-rich element with promoter activity, along
with CTCF and cohesin that occupy upstream sites, stimulates
transcription toward the telomere in half of human chromosomes
[14], while it is absent in the rest [13].
TERRA often lacks a poly(A) sequence, which is unusual for a
Pol II-transcript, and includes a short UUAGGG tract (<200 nt),
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leading to rapid turnover [15]. Poly (A)2 TERRA associates with
telomere chromatin [15]. Notably, depletion of TERRA from
telomeres provokes persistent DNA damage that results in
aberrant metaphase telomeres, substantiating its protective func-
tion as a constitutive factor of telomeres [16,17]. Consistent with
this notion, TERRA excludes RPA from, and promotes POT1
loading onto G-tails in late S phase to ensure the end protective
state [18].
It is suggested that changes in TERRA levels are accompanied
by epigenetic modifications at telomeres during developmental
stages and de-differentiation into iPS cells [12,19]. However, the
molecular readers that appropriately interpret the transcriptional
status of TERRA into telomere homeostasis have remained
elusive.
One central difficulty in mammalian telomere biology derives
from the highly repetitive and polymorphic nature of the DNA
sequences at the telomere and subtelomere. This makes it
challenging to pursue the dynamics of individual telomeres at
high spatio-temporal resolution. We addressed this problem by
exploiting telomere seeding, in which transfection of cloned
telomere DNA repeats (telomere-targeting vector) occasionally
establishes a de novo telomere at the distal end of the integration site
[20–22]. To avoid uncertainty and selection bias inherent to the
random integration of the telomere-targeting vector, we instead
utilized a gene-targeting technique in DT40 immortalized chicken
lymphoblasts to site-specifically induce telomere seeding on a
particular human chromosome [23]. Here we used microcell-
mediated chromosome transfer to establish a human artificial
chromosome (HAC) that is retained in mammalian cells. We
analyzed the replication, transcription, and the binding of
telomere-specific proteins at the seeded telomere and subtelomere.
Investigations focusing on a single telomere in mammalian cells
will be invaluable to fully understand the dynamic nature of
telomere metabolism.
Materials and Methods
Cell lines and cell culture
A DT40 microcell hybrid cell line (DT40(#21)puro339)
containing a q-arm truncate of human chromosome 21 (hChr21),
which in this paper is called HAC#21, was previously established
[23]. As described, a DT40 hybrid carrying a single copy of
hChr21, DT40(#21), was used to obtain HAC#21 by integration
of the telomere-seeding vector, pBS-TEL/Puro/21q. DT40
hybrid cells were cultured at 40uC in Roswell Park Memorial
Institute (RPMI) 1640 medium (Invitrogen) containing 10% fetal
bovine serum (FBS) (JRH Biosciences), 1% chicken serum
(Invitrogen), 50 mM 2-mercaptoethanol (Sigma) and penicillin-
streptomycin (PC-SM) (Gibco), under selection with 0.3 mg/ml
puromycin (Sigma). HeLa and NIH-3T3 cells, and their
HAC#21-transferred derivatives were maintained in Dulbecco’s
modified Eagle’s medium (DMEM) (Nissui) supplemented with
10% FBS and PC-SM.
Microcell-mediated chromosome transfer (MMCT)
HAC#21 was transferred from DT40(#21)puro339 to HeLa or
NIH-3T3 cells by MMCT, following an established protocol [23].
Briefly, the donor cells were cultured with medium containing
0.05 mg/ml colcemid (Gibco) and 20% FBS for 12 hrs to allow
microcell formation. In FBS-depleted medium with 0.01 mg/ml
cytochalasin B (Sigma), microcells were harvested by centrifuging
16109 DT40 hybrid cells attached on flasks (Nalgene Nunc)
coated with poly-L-lysine (Sigma) for 1 hr at 8,000 rpm, at 34uC.
After three rounds of filtration to avoid contamination of the host
cells, microcells were gently suspended in DMEM containing
0.05 mg/ml phytohemagglutinin P. Microcells were then dropped
onto about 36106 attached HeLa or NIH-3T3 target cells that
had been pretreated immediately beforehand with 47% polyeth-
ylene glycol 1000 (WAKO) for exactly 1 min. HAC#21-carrying
clones were selected with 0.5–1.5 mg/ml puromycin.
Fluorescence in situ hybridization (FISH)
Metaphase spreads were prepared by following a standard
protocol. For FISH on interphase chromosomes, cells were pre-
permeabilized on ice for 5 min with cytoskeleton (CSK) buffer
(20 mM HEPES-KOH, pH 7.4, 50 mM NaCl, 3 mM MgCl2,
and 0.3 M sucrose) containing 0.1% Triton X-100, fixed on ice for
10 min in PBS with 3.7% formaldehyde and 0.25% glutaralde-
hyde, and permeabilized with CSK buffer with 0.5% Triton X-
100. Hybridization was performed at 37uC overnight in 50%
formamide, 26 SSC (0.3 M NaCl, 30 mM sodium citrate,
pH 7.0), 1 mg/ml salmon sperm DNA, 10% dextran sulfate,
and 56Denhardt’s (0.1% Ficoll, 0.1% polyvinylpyrolidone, and
0.1% bovine serum albumin). The probes were labeled by nick-
translation (Roche) with digoxigenin-conjugated dUTP using a-
satellite DNA clone p11-4 [24], which is derived from centromere
DNA on human chromosome 21. A biotinylated oligonucleotide
with hChr21/13-specific a-satellite sequence, 59-TGTGTACC-
CAGCCAAAGGAGTTGA-39, was used for interphase FISH
analysis [25]. The digoxigenin signal was detected with an anti-
digoxigenin–rhodamine complex (Roche). The biotin signal was
detected with a streptavidin-Alexa488 complex (Molecular Probes)
following sequential layers of streptavidin-Alexa488 and biotiny-
lated anti-avidin D antibody (Vector). After DNA-staining with
Hoechst 33342 (Molecular Probes), the slides were mounted with
VectaShield without dye (Vector Laboratories), and analyzed with
a Delta Vision microscope (Applied Precision). Images taken in Z-
sections were deconvoluted using SoftWoRx (Applied Precision).
Southern hybridization
Southern blot was performed as described [26], with slight
modification. Briefly, genomic DNA was restricted, separated on a
0.7% agarose gel, depurinated, then transferred to Hybond N+
membranes (Amersham) by alkaline transfer. Blots were UV-
crosslinked (Stratagene) and hybridized in Church buffer over-
night at 55–65uC depending on probes. The probes were labeled
by random priming (Roche) with 50 mCi of a32P-dCTP. Probe
DNA specific for plasmid sequence was obtained by PCR using a
cloned plasmid template, or a fragment excised from Pgk-puro
cloned in pBluescript II SK(+). To prepare a genomic probe, a
specific PCR-amplified genomic fragment was cloned, sequence-
verified, excised, and gel-purified. After hybridization, the
membrane was washed in 1% SDS, 40 mM sodium phosphate
(pH 7.2), and 1 mM EDTA, and exposed to a storage phosphor
screen (FUJIFILM) which was then visualized with a Typhoon
9400 phosphor image analyzer (GE Healthcare).
BAL31 assay
Genomic DNA was incubated with 0.033 U/ml BAL31
(TaKaRa), and at designated time points aliquots were removed,
and the reaction was stopped by adding 20 mM EGTA. After
phenol/chloroform/isoamyl alcohol extraction and alcohol pre-
cipitation, DNA was analyzed by Southern hybridization.
Cell-cycle synchronization and replication timing analysis
HAC#21-HeLa cells were treated with 2 mM thymidine for
16 hrs, released into normal medium for 11 hrs, and then treated
Human Artificial Chromosome Telomeres
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with 1 mg/ml aphidicolin for 14 hrs. Following release, cells were
pulse-labeled with 50 mM 5-bromo-29-deoxyuridine (BrdU) for
one-hour intervals, chased with normal medium, and harvested
9 hrs post release. For monitoring cell cycle progression, a parallel
sample of cells was harvested at each time point, stained with
propidium iodide, and analyzed for DNA content by FACS
Calibur (BD). For replication analysis, genomic DNA, extracted
using a Wizard Genomic DNA Extraction kit (Promega), was
sonicated to a few hundred bp using a Bioruptor (BioRad). 2 mg of
the sonicated DNA and 2 ng of BrdU-substituted/sonicated
Escherichia coli DNA were heat-denatured in a mixture and
immunoprecipitated with 5 mg of anti-BrdU antibody (Roche,
BMC9318) in 100 ml of IP buffer (0.05% Triton X-100, 140 mM
NaCl, and 10 mM sodium phosphate, pH 7.2) for 30 min at room
temperature (RT), and further rotated for 30 min with 20 ml of
Dynal M-280 sheep anti-mouse IgG (Invitrogen). The beads were
washed four times each for 5 min with 500 ml of IP buffer, eluted
twice in 100 ml of 1% SDS/TE at 100uC for 3 min, and DNA was
de-proteinized, purified, and subjected to real-time PCR as in
ChIP. The graphs and regression curves were drawn with
KaleidaGraph (Hulinks).
Chromatin immunoprecipitation (ChIP)
ChIP was done essentially as described [26], with slight
modifications. Briefly, 16107 cells suspended in phosphate-
buffered saline (PBS) (Nissui) were fixed by adding 1% formalde-
hyde for 10 min at RT. After the reaction was quenched with
125 mM glycine, the fixed cells were washed in PBS and lysed on
ice for 10 min in 100 ml of Cell Lysis buffer (1% SDS, 10 mM
EDTA, 50 mM Tris, pH 8.0, and protease inhibitors (Roche)).
The lysates were diluted with 4-volume Cell Lysis buffer without
SDS, and sonicated with a Bioruptor (BioRad) at 4uC, 10 or
15 min in total, with equal on/off switching of 15 sec. Cleared
sonicates were diluted 10-fold with 1% Triton X-100, 150 mM
NaCl, 2.5 mM KCl, 5 mM Na2HPO4, 1.5 mM KH2PO4,
10 mM EDTA, 25 mM Tris, pH 7.6, 10% glycerol, 1 mM
dithiothreitol, and protease inhibitors (Roche), then mixed with
each antibody and 40 ml of Dynal M-280 sheep anti-rabbit IgG or
sheep anti-mouse IgG, or 80 ml of Dynal M-450 sheep anti-rat IgG
magnetic beads (Invitrogen), and rotated at 4uC overnight. Beads
were washed successively with 750 ml of low salt NET buffer (0.5%
NP-40, 1 mM EDTA, 1 mM EGTA, 150 mM NaCl, 5 mM
MgCl2, and 50 mM Tris, pH 8.0), high salt NET buffer (NET
buffer with 300 mM NaCl), LiCl buffer (10 mM Tris, pH 8.0,
250 mM LiCl, 1 mM EGTA, 0.5% NP-40 and 0.5% Triton X-
100), and TE (10 mM Tris, pH 8.0, 1 mM EDTA). Each wash
was for 5 min at 4uC. The number of repetitions of each wash step
varied, depending on the antibodies used. The DNA-protein
complex was eluted from the beads in 1% SDS, 0.1% NaHCO3 at
68uC for 10 min, and de-crosslinked at 65uC overnight after
addition of an equal volume of 300 mM NaCl, 100 mg/ml RNase
A. Co-precipitated DNA was extracted with phenol/chloroform/
isoamyl alcohol, ethanol-precipitated with 2 ml of 20 mg/ml
glycogen (Nacalai) at 280uC, and dissolved in TE. 5% of the
DNA was used for real-time PCR, performed with an ABI PRISM
7000 or StepOne Plus (Applied Biosystems), using Power SYBR
green PCR master mix (Applied Biosystems). The PCR program
consisted of 45 cycles of 95uC, 5 sec, and 60uC, 31 sec.
Antibodies
For ChIP, normal rabbit IgG (Santa Cruz, sc-2027), anti-
histone H3 (Abcam, ab1791), anti-TRF1 (in-house), anti-TRF2
(Millipore, #05-521), anti-TPP1 (in-house) and anti-Pol II C-
terminus domain (CTD) (Abcam, ab5408; clone 4H8) were used.
Anti-phospho Ser-2 CTD (clone 3E10) and anti-phospho Ser-5
CTD were previously described [27]. Immunoblotting utilized
anti-nucleolin (Abcam, ab13541), anti-tubulin (Sigma, T3526),
anti-hnRNPA1 (Abcam, ab10685) anti-histone H2B (Millipore,
#07-371), and anti-GAPDH (Millipore, clone 6C5).
RNA preparation and RT-PCR/RT-real-time PCR
To extract RNA in the nuclear fraction, cells were trypsinized,
washed with PBS, and extracted with 250 ml of NP-40 buffer
(10 mM Tris, pH 7.5, 10 mM NaCl, 3 mM MgCl2, 0.5% NP-40,
40 U/ml RNasin (Promega), and 1 mM dithiothreitol) on ice for
10 min. Nuclei were pelleted by centrifugation at 5006g for 5 min
at 4uC, washed once with NP-40 buffer, and processed as in total
RNA extraction. Total RNA was extracted using an RNeasy Mini
kit (Qiagen) with on-column DNase I digestion following the
manufacturer’s protocol. 1 or 2 mg of RNA was reverse-
transcribed with random nonamers or a telomere-specific 59-
(CCCTAA)5-39 primer at 55uC using AMV reverse-transcriptase
XL (TaKaRa). cDNA was subjected to either real-time PCR as
described for ChIP analyses, or PCR using LA-taq DNA
polymerase (TaKaRa).
Purification of telomeric repeat-containing RNA and
Northern hybridization
Total RNA (50 mg) and 5 pmol of biotinylated oligonucleotide
containing 59-(CCCTAA)5-39 repeat were combined with Binding
Buffer (10 mM Tris (pH 7.6), 0.5 M NaCl and 1 mM EDTA) in a
total volume of 300 ml. The mixture was heated at 65uC for 2 min,
then cooled on ice, and added to 10 mg of Dynal M280
Streptavidin magnetic beads. After gentle rotation at RT for
1 hour, the beads were washed three times for 5 min at RT with
300 ml Wash buffer (10 mM Tris-Cl (pH 7.6), 150 mM LiCl,
1 mM EDTA). An aliquot of 1/25 of the washed beads was
removed for RT-PCR to check the enrichment of TERRA, and
the rest was used for Northern hybridization. For Northern
hybridization, the beads complex was heat-denatured and
separated on a denaturing gel (1% Seakem GTG agarose, 6%
formaldehyde and 16Goldberg buffer (40 mM MOPS (pH 7.2),
5 mM sodium-citrate, 0.5 mM EDTA)) in 16 Goldberg buffer.
The gel was neutralized in 0.25 M ammonium acetate (pH 5.0)
and stained with SYBR Gold, then transferred onto Hybond N+
membrane in 25 mM sodium phosphate buffer (pH 6.5). The blot
was UV-crosslinked at 0.12 J/m2 and hybridized with a 32P-
labeled probe in 7% SDS, 0.5 M sodium phosphate (pH 6.5),
1 mM EDTA overnight at 65uC. The hybridized membrane was
washed in 1% SDS, 40 mM sodium phosphate (pH 6.5) and
exposed to a phosphor screen. The autoradiograph was analyzed
with a Typhoon 9400 phosphor imager and ImageQuant software
(GE Healthcare). The densitometric data was graphed using Excel
(Microsoft).
59 Rapid amplification of cDNA ends (59 RACE)
The transcription start site for HAC-telRNA was determined
using a SMART RACE cDNA amplification kit (Clontech)
according to the manufacturer’s protocol. Reverse-transcription
was performed with a pBluescript-specific primer using 0.5 mg of
RNA from the nuclear fraction, followed by PCR with 45 cycles of
95uC for 15 sec, 60uC for 20 sec, and 72uC for 3 min.
Subcellular fractionation and quantification of RNA
Cell fractionation was done essentially as described [15]. For
quantification of RNA, RNA was purified from a uniform portion
of each fraction with an RNeasy Mini kit (Qiagen) as described
Human Artificial Chromosome Telomeres
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above. cDNAs were then synthesized with a mixture of gene-
specific and 59-(CCCTAA)5-39 primers, and subjected to real-time
PCR analyses as described in ChIP.
siRNA
A cocktail of siRNA oligonucleotides against human TRF1
(Cosmo Bio, SHF27A-2210-C) or a negative control was
transiently transfected into cells using Lipofectamine 2000
(Invitrogen), according to the manufacturers’ protocols. Total
RNA was prepared from cells 48 hrs post-transfection. RT-PCR
gels were stained with SYBR Gold (Invitrogen), and signals were
quantified by Typhoon 9400 and ImageQuant software.
Primer sequences
PCR primers used for probe construction in Southern































Gene-specific RT primers in RT-PCR/RT-real-time PCR









PCR primers in RT-PCR/RT-real-time PCR experiments are
as follows:
59 RACE for HAC-telRNA: 59-GCAGTGCTGCCATAAC-
CATGAGTG-39
HAC-telRNA (unspliced and spliced) fwd: 59-TCAAGCT-
TATCGATACCGTCGACC-39
HAC-telRNA (unspliced and spliced) rvs: 59-GTGCTGCAA-
GGCGATTAAGT-39
HAC-telRNA (variant 1) fwd: 59-CTGCGCCTTATCCGT-
TGC-39
HAC-telRNA (variant 1) rvs: 59-GATAAATCTGGAGCCG-
GTGA-39
HAC-telRNA (variant 1 and 2) fwd: 59-GCGCTTTCTCAT-
AGCTCACG-39
HAC-telRNA (variant 1 and 2) rvs: 59-ACGACGGGGAGTC-
AGGCAACGG-39
Xp-Yp TERRA fwd: 59-CCCTCTGAAAGTGGACCTAT-39





















HeLa and NIH-3T3 subclones that contain an artificial
chromosome
We have previously reported a human artificial chromosome
(HAC) maintained in chicken DT40 cells [23]. Briefly, a human
chromosome 21 (hChr21) that possessed a drug selection marker
was transferred by microcell-mediated chromosome transfer
(MMCT) from mouse A9 hybrid host cells containing hChr21 to
DT40 cells, a cell line highly proficient for DNA homologous
recombination. A resulting stable cell line, DT40#21, contained a
single copy of hChr21. We transfected a telomere-targeting vector
to DT40#21 cells (Fig. 1A). The linearized pBluescript-based
vector contained 1-kb telomere DNA repeats at one end for
induction of de novo telomere formation, and a puromycin
resistance gene for selection of transfected clones (Fig. 1A). At
the other end of the vector was a 5-kb sequence of the native long
arm of hChr21 (hChr21q) that targeted integration of the vector at
this particular site (nt 15,114,270–15,119,260 on RefSeq
(GRCh37.p10), located 0.7-Mb distal to the centromere of
hChr21). The predicted size of the truncated chromosome was
approximately 15 Mb, corresponding to one-third of that of
hChr21 (48 Mb, http://www.ncbi.nlm.nih.gov/mapview/maps.
cgi?taxid = 9606&chr = 21). After transfection, we chose a puro-
mycin-resistant DT40 clone (DT40(#21)puro339) carrying a
single copy of hChr21 with a truncated hChr21q that had
undergone homologous recombination (Fig. 1A), which we
hereafter call HAC#21 (human artificial chromosome derived
from hChr21).
We transferred HAC#21 from DT40(#21)puro339 cells to
HeLa and NIH-3T3 cells via MMCT. In one experiment,
microcells harvested from 16109 DT40 hybrid cells were fused
with 36106 attached HeLa or NIH-3T3 target cells (Fig. 1A). In
total, 3 and 38 puromycin-resistant clones were obtained from
Human Artificial Chromosome Telomeres
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Figure 1. Experimental design of the study. A. The telomere-targeting vector containing a hChr21q-homologous region (striped) was targeted
to the long arm of hChr21 in DT40 hybrid cells (left panel). Puro-resistant clones that possessed a mini-chromosome HAC#21 with a de novo telomere
were obtained (red triangles, middle panel). HAC#21 was transferred to HeLa or NIH-3T3 cells (right) to produce HAC#21-HeLa and HAC#21-NIH-
3T3 cells, respectively, by microcell-mediated chromosome transfer. HAC#21 contains vector backbone-derived unique DNA sequences in host cells,
as highlighted in red in the plasmid map. B. Metaphase spreads of HAC#21-HeLa chromosomes were hybridized with an alphoid DNA specific to
hChr21 and hChr13 (red), and stained for DNA (blue). In addition to the host chromosomes, a small-sized putative mini-chromosome hybridized with
the probe, and was consistently spatially distinct from host chromosomes (arrowhead). C. Restriction map of hChr21 versus the presumptive HAC#21
indicating the positions of probes (bars). D. BAL31 sensitivity. Genomic DNAs obtained from indicated cells were treated for 0 min (0) or 10 min (10)
with exonuclease BAL31, and subjected to Southern hybridization using indicated probes. +HAC#21 indicates HAC#21-HeLa DNA. The vector
fragments detected with the targeting vector-specific probe pBSa (a smear in top left and a band in top right) were sensitive to BAL31 treatment
(bracket), whereas a fragment internal to hChr21 was resistant (bottom, 21b). The stronger intensity of the 21b-positive band in lane 1 compared to
lanes 2 and 3 was due to overloading of HeLa DNA compared to HAC#21-HeLa DNA. E. Telomere length of HAC#21 in NIH-3T3 cells. The vector
fragment containing telomere repeats was detected in BglII digests of DNAs obtained from HAC#21-NIH-3T3 cells (+HAC#21) by Southern
hybridization using a pBSb probe.
doi:10.1371/journal.pone.0088530.g001
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1.56107 cells of HeLa and NIH-3T3 recipient cells (transforma-
tion efficiencies, 261027 and 2.561026/recipient cell) respective-
ly, in five independent experiments. Among these puromycin-
resistant clones, we found that 13 out of 22 NIH-3T3 clones
showed smeared telomere signals in an experiment similar to
Fig. 1E, suggesting that approximately half of the NIH-3T3 clones
possessed HAC (a rough estimate of MMCT efficiency was
approximately 386(13/22)/(1610965) = 4.561029 HAC-positive
NIH-3T3 clone/donor DT40(#21)puro339 cell). We further
investigated one each from the HeLa and NIH-3T3 clones, as
described below (HAC#21-HeLa and HAC#21-NIH-3T3 cells,
respectively). We detected HAC#21 in HAC#21-HeLa cells by
fluorescence in situ hybridization (FISH) using an alphoid DNA
probe that detects the hChr21 and hChr13 (human chromosome
13) centromeres (hChr13/hChr21 alphoid probe) [24]. In
metaphase spreads of HAC#21-HeLa cells, we consistently
detected FISH signals on a small chromosome that appeared as
a dot after DNA staining (Fig. 1B, arrowhead), as well as on native
hChr21 and hChr13 chromosomes. We examined the copy
number of HAC#21 in HAC#21-HeLa cells by hybridizing the
hChr13/hChr21 alphoid probe in interphase HeLa cells, and
HAC#21-HeLa cells cultured for 6 weeks with or without
puromycin selection (Fig. S1A). The probe produced a median
number of four independent signals per nucleus in control HeLa
cells, whereas five signals were detected in HAC#21-HeLa cells
cultured in the presence or absence of puromycin. The single extra
FISH signal in cells harboring HAC#21 and cultured without
puromycin selection suggests the presence of a single copy of
HAC#21 that was stably maintained. Similarly, we detected a
single hChr13/hCh21 alphoid sequence-specific signal in individ-
ual interphase HAC#21-NIH-3T3 cells, but not in the parental
NIH-3T3 cells (data not shown). Taken together, we conclude that
a single copy of HAC#21 is maintained in HAC#21-HeLa cells
and HAC#21-NIH-3T3 cells, independently of the host chromo-
somes.
We characterized the structure of the newly formed telomere of
HAC#21 by Southern hybridization. A probe corresponding to
the region derived from the hChr21-homologous sequence of the
targeting vector (21a in Fig. S1B) detected a 6.3-kb band in
HindIII digests obtained from both HeLa and HAC#21-HeLa
cells, as expected with the native hChr21 (Fig. S1B). In addition,
we detected a 7.5-kb band specifically in HAC#21-HeLa cells
(Fig. S1B, arrow). The size of the fragment exactly matched the
predicted length of a HindIII junction fragment spanning the
boundary between hChr21q and the targeting vector-derived
sequence (Fig. S1B). The signal of the native hChr21-derived 6.3-
kb band was more intense than that of the HAC#21-derived 7.5-
kb band. This was probably caused by segmental duplications
involving the 6.3-kb fragment in the human genome (found with
Chr21q11.1, Chr21q22.1, Chr2, Chr18 and Chr3) [28]. The 7.5-
kb band, but not the 6.3-kb band, was also detected with a probe
corresponding to the HAC#21-specific puromycin-resistance gene
region (puro) (Fig. S1B). In summary, the 7.5-kb band was positive
for both hChr21 sequence (probe 21a) and targeting vector-
specific sequence (puro), suggesting that the targeting vector had
integrated in the predicted region of hChr21q, as expected from
the homology-mediated integration.
HeLa and NIH-3T3 cells are telomerase-positive and displayed
telomere lengths of several kb up to thirty kb, by terminal
restriction fragment analysis (Fig. S1C, lanes P and HeLa). The
telomere-containing fragment typically appears as a smeared
hybridization signal that is sensitive to BAL31 exonuclease
treatment prior to restriction digestion [29]. When genomic
DNAs from HAC#21-HeLa cells were treated with BAL31 for
10 min, digested with BamHI, and hybridized with a probe
located distal to the most terminal BamHI site on the targeting
vector (pBSa in Fig. 1C), accordingly, the smeared HAC#21-
specific band migrated faster (Fig. 1D, top left). This result is
consistent with the predicted structure of the seeded telomere, in
which the probe detects a BamHI fragment containing the
telomere repeats. Using HindIII digests, the pBSa probe detected
a discrete 3.5-kb band, rather than a smear, as expected from the
presence of a HindIII site distal to the region hybridized with the
probe (Fig. 1D, top right, 0 min). The 3.5-kb signal became a
faster-migrating smear in BAL31-treated DNA compared to
untreated DNA, whereas a chromosome-internal fragment on
the short arm of hChr21 detected by the 21b probe was BAL31-
resistent (Fig. 1D, bottom), again indicating that the HindIII
fragment detected by the pBSa probe was localized close to the
terminus of HAC#21.
We deduced the length of the seeded telomere of HAC#21 by
subtracting the nucleotide length of subtelomeric DNA from that
of the terminal restriction fragments. By densitometric analysis, we
estimated that the smeared signal in Fig. 1D (BAL31-untreated
HAC#21-HeLa, lane 2) ranged from 5.2 to 10.2 kb. The BamHI
fragment contained a 4.7-kb segment of subtelomeric DNA
(Fig. 1C), leading to an estimated 0.5 to 5.5 kb length of the
seeded telomere repeat DNA in HAC#21-HeLa cells. Similarly,
in HAC#21-NIH-3T3 cells, by subtracting a 3.5-kb subtelomeric
DNA portion from the BglII-digested terminal fragment of
HAC#21 (detected by the pBSb probe in Fig. 1E, lane 2), we
estimated that the length of the seeded telomere DNAs of
HAC#21 ranged from 3.5 to 8.1 kb. These calculations suggest
that HAC#21 telomere DNA is longer in HAC#21-NIH-3T3
than in HAC#21-HeLa cells. We produced multiple independent
HAC#21-containing NIH-3T3 clones in addition to the clone
described above. All examined NIH-3T3 clones showed longer
HAC#21 telomere DNA compared to that of HAC#21-HeLa
cells, suggesting that the observations of telomere length were not
clone-specific among different NIH-3T3 clones. Native telomeres
in NIH-3T3 cells are generally longer than in HeLa cells (Fig.
S1C). These results suggest that the length of the seeded telomeres
was controlled similarly to the native telomeres.
Telomere regions of HAC#21 are replicated during mid-S
phase in HeLa cells
To analyze the replication timing of the telomere region in
HAC#21, we synchronized HAC#21-HeLa cells at the start of S
phase by sequential treatments of cells with thymidine and
aphidicolin (Fig. 2A). The synchronous culture was released from
the G1-S block by culturing the cells in media without the drug,
and split into aliquots. Successive aliquots were labeled with BrdU
for 1 hr at consecutive one-hour intervals and chased in the
absence of BrdU until 9 hr post-release when most cells exited
from S phase. BrdU-labeled nascent DNA was purified by
immunoprecipitation with an anti-BrdU antibody, and enrich-
ment of test DNAs was quantified by real-time PCR. All loci
analyzed showed a single 1-hr peak interval, during which the
BrdU incorporation was greatest (Fig. 2B). It is known that ADH5
and the gamma-globin gene replicate in early and late S phase,
respectively [30,31]. When cumulative BrdU incorporation was
correlated with specific test loci in fractions covering the S phase
progression, we found that ADH5 and gamma-globin loci
replicated at early and late S phase, respectively, as expected
(Fig. 2C). To examine the replication kinetics of HAC#21, we
chose two primer sets, x and z, which were unique to the
HAC#21 subtelomere (Fig. 2C). Regions amplified by primer sets
x and z are located 0.1-kb and 3.5-kb proximal to the telomere
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repeat DNAs of the seeded telomere of HAC#21 (regions x and z,
respectively). We found that regions x and z synchronously
replicated at mid-S phase (Fig. 2B and C). These results indicate
that the telomere-proximal region of the seeded telomere of
HAC#21, which is devoid of any endogenous hChr21 subtelo-
mere DNA sequence, synchronously replicates at mid-S phase in
HAC#21-HeLa cells.
Spreading of telomere proteins at the telomere-proximal
DNA of HAC#21 in HeLa cells
We conducted chromatin immunoprecipitation (ChIP) to
examine if the HAC#21 telomere is associated with shelterin
proteins (Fig. 3). First, the specificities of anti-TRF1, TRF2, and
TPP1 antibodies were tested by immunoblotting of HeLa cell
extracts, and proteins with the expected mobilities of TRF1,
TRF2, and TPP1, respectively, were detected (Fig. S2A,
arrowheads). DNAs obtained from immunoprecipitates with
anti-TRF1, TRF2, and TPP1 antibodies hybridized with a
telomere DNA probe, but not with a centromeric alphoid DNA
probe. In contrast, both probes detected anti-histone H3
immunoprecipitates, as expected.
We analyzed co-precipitated DNA by real-time PCR, using
primer sets x, y, and z (Fig. 3B). The primer set y amplifies a
HAC#21 subtelomeric region 0.7-kb proximal to the HAC#21
telomere repeats (region y). In the quantitative ChIP experiment,
Figure 2. The seeded subtelomere is replicated in mid-S phase in HeLa cells. A. S-phase progression analyzed by flow-cytometry of G1/S-
released cells after thymidine-aphidicolin double-block and propidium iodide staining. B. Histograms indicating the amounts of incorporated BrdU at
a test locus during each one-hour pulse in S phase, as determined by real-time PCR quantification of immunoprecipitated genomic DNA by anti-BrdU
(shown in arbitrary units). x and z indicate PCR regions in the HAC#21 subtelomere shown in C. Each graph is fitted to a normal distribution (red). C.
Replication kinetics represented in the cumulative plots of BrdU-incorporation in B, with fitting curves. The distal subtelomeric DNA in HAC#21 (PCR
regions x and z) is replicated with timing between early (ADH5) and late (c-globin) in S phase.
doi:10.1371/journal.pone.0088530.g002
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TRF1, TRF2, and TPP1 were enriched at region x (0.1-kb
proximal to the telomere repeats). Interestingly, the enrichments of
both TRF1 and TRF2 were significant at region y, albeit at
reduced levels compared to region x, while TPP1 appeared absent
at region y. In these ChIP experiments, the length of sonicated
DNA was largely in the range of less than five hundred bp (Fig.
S2B). Given that region y is 0.7 kb centromeric to the telomere
repeat DNA array, the positive ChIP data for TRF1 and TRF2
using region y probe suggests that TRF1 and TRF2 bound with
the subtelomeric DNA. It is nevertheless possible that the
differential enrichment of TRF1 and TRF2 versus TPP1 at region
y was caused by different efficiencies of the three antibodies in
immunoprecipitation. Alternatively, TRF1 and TRF2 indeed may
associate with subtelomeric chromatin more proximally compared
to TPP1. It was reported that TRF1 and TRF2 are ten times as
abundant as TPP1 in several cancer cell lines [32], and as such it is
possible that the different distributions were caused by a mass
effect. Importantly, we could not detect any binding of the three
telomeric proteins at region z (3.5-kb proximal). Thus, we
concluded that TRF1, TRF2, and TPP1 bind to the subtelomeric
Figure 3. Telomere-binding proteins spread to the seeded subtelomere in HeLa cells. A. Dot blots of chromatin immunoprecipitates
indicating specificity of telomere-binding proteins. Left, the telomere-repeat probe. Right, the alphoid probe. Results shown are from three
independent immunoprecipitation experiments (ChIP #1-#3). B. The seeded subtelomere was analyzed by real-time PCR after ChIP. The percentage
of input DNA precipitated is shown along the distance from telomere repeats in HAC#21 (0.1-, 0.7- and 3.5-kb apart regions were analyzed). Bars
indicate s.d. of three independent ChIP experiments.
doi:10.1371/journal.pone.0088530.g003
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region of HAC#21. In summary, it was suggested that the
shelterin complex is localized at the subtelomere of the HAC#21
telomere. Anti-histone H3 antibody significantly precipitated
regions x, y, and z. Therefore, nucleosomes seem to be formed
in the vicinity of the telomere repeats.
Telomeric repeat-containing RNA is transcribed from the
seeded subtelomere
We investigated whether the seeded telomere of HAC#21
produced any RNA transcripts using RT-PCR experiments. We
enriched the nuclear RNA fraction, in which TERRA is
exclusively contained [11,15], and synthesized cDNA using a
telomere-specific primer (CCCTAA-primer). This primer is
comprised of a 20-nt 59 unique sequence, used for tagging the
cDNA, followed by a 59-(CCCTAA)5-39 sequence at its 39 end, so
that only RNAs containing telomere repeats will be reverse-
transcribed. We prepared specific PCR primers to amplify the
telomere-adjacent region unique to either HAC#21 or chromo-
some Xp-Yp, enabling us to exclusively detect transcripts from
respective chromosomal ends. TERRA derived from chromosome
Xp-Yp served as a control [11]; the Xp-Yp TERRA signals were
detected in an RT-dependent manner in both HAC#21-positive
and -negative HeLa cells (Xp-Yp in Fig. 4A). We detected a PCR
signal using HAC#21-specific primers only in HAC#21-HeLa,
but not in HeLa cells. The signal was dependent on the presence
of reverse-transcriptase (RT) in the reaction, demonstrating that
the telomere DNA repeats of the seeded HAC#21 telomere were
transcribed in HAC#21-HeLa cells. Similar results were obtained
with HAC#21-NIH-3T3 cells (data not shown).
We determined the transcription start site (TSS) by conducting
59-RACE (rapid amplification of cDNA ends), using an RT primer
specific to the unique sequence of the targeting vector (RT in
Fig. 4B). We obtained a discrete band amplified by 59-RACE in
HAC#21-HeLa and HAC#21-NIH-3T3 cells, but not in HeLa
or NIH-3T3 cells. Sequencing of the PCR product showed that
the transcription started at two closely positioned nucleotides that
resided within the targeting vector backbone-derived sequence in
HAC#21-HeLa cells, which were 2.3-kb proximal to the telomere
repeat DNA (shown as blue circles in Fig. 4B and 4C).
Interestingly, inspection of the nucleotide sequence around the
TSS’s identified a ‘‘tataaa’’ sequence 27 nt upstream of the first
transcription site (Fig. 4C). This TATA-box-like sequence may
have specified initiation of transcription of the telomeric repeat-
containing RNA, which hereafter we refer to as HAC-telRNA.
The C-terminal domain (CTD) of the largest subunit of RNA
polymerase II (Pol II) complex contains tandem repeats of seven
amino acids (the consensus sequence is YSPTSPS) in a wide
variety of eukaryotic species. The serine and threonine residues of
the heptad repeat are phosphorylated depending on the step at
which the Pol II is committed in transcription [33]. In a simplified
view, phosphorylated Ser-5 (S5P) of CTD is most abundant when
Pol II transcribes the 59-end of genes. Accordingly, S5P is enriched
at active promoters. In contrast, phosphorylation of Ser-2 (S2P) is
abundant with processively elongating Pol II. We examined the
CTD phosphorylation of Pol II associated with the DNA region
encoding HAC-telRNA in ChIP experiments using antibodies
specific to S2P or S5P phosphorylated Pol II [27], or Pol II
irrespective of its CTD phosphorylation status (Fig. 4D). In control
experiments, we found that S5P-Pol II was highly enriched in the
region about 0.1-kb downstream of the TSS of the c-actin gene
(ACTG1), as expected. We could not obtain workable real-time
PCR primers for the region immediately downstream of the HAC-
telRNA TSS for technical reasons. We therefore conducted Pol II
ChIP experiments using a primer set amplifying a region 0.2-kb
upstream of the TSS (region w in Fig. 4D). We detected binding of
Pol II S5P at the region w, albeit to a lesser extent than at the TSS
of ACTG1, suggesting that transcription of HAC-telRNA started
from a region close to the region w. The absence of S5P Pol II at
the regions x or y suggests that there is not an alternative TSS for
HAC-telRNA near the telomere repeats on HAC#21. In contrast,
Pol II S2P, a mark for elongating Pol II, was present at the regions
x and w. Collectively, these results indicate that Pol II initiates
transcription of HAC-telRNA at TSS’s within the integrated
targeting vector sequence, and elongation proceeds toward the
telomere repeats.
We found that HAC-telRNA was generated in two variant
forms showing different lengths (variants 1 and 2, Fig. 5A). The
variants lacked overlapping genomic sequences of 551 nt and
525 nt, respectively, in their cDNA sequences. The missing
sequences started with distinct nucleotides (..ATCCGgtaac.. in
variant 1, and ..ACCCGgtaag.. in variant 2; lowercase letters
indicate the missing region), which were 26-nt apart, and
terminated at the common nucleotide (..ccatagTTGCCTGAC..).
Interestingly, these start and terminal nucleotide sequences match
intronic consensus donor and acceptor sequences. Based on this
sequence information, we confirmed splicing of HAC-telRNA by
RT-PCR using cDNA generated with the (CCCTAA)5 primer.
We prepared two PCR primer sets (primers Q and R; and S and T
in Fig. 5A). In both sets, one primer was encoded by a presumptive
exon (primers S and R), and the other corresponded to a sequence
that spans a putative splice junction (primers T and Q). Primer sets
(Q and R) should specifically detect splice variant 1, but not
variant 2 (Fig. 5A, upper panel). Indeed, the primer sets produced
specific PCR products in two independent clones of HAC#21-
NIH-3T3 (#5 and #22 in Fig. 5A, left lower panel) and one
HAC#21-HeLa clone (#1 in Fig. 5A, left lower panel), but not in
their parental NIH-3T3 or HeLa cells (P in Fig. 5A, left lower
panel). Coincidentally, the 39-most nucleotides of the presumptive
upstream exons of variants 1 and 2 were CCG-39. Because the 39-
end of primer T is CGG-39, primer T will anneal with both
variant 1 and 2 (Fig. 5A, upper panel). Thus, the primer set (S, T)
will detect both variants 1 and 2. Indeed, we observed two RT-
PCR products from HAC#21-HeLa cells using that primer set,
and the respective sizes differed by about 26 bp, as predicted
(Fig. 5A, right panel). The relative signal intensities of the two
bands were similar, suggesting that HAC-telRNA splice variants 1
and 2 were produced at similar levels.
HAC-telRNA shares features with TERRA
We asked whether HAC-telRNA showed characteristic features
in common with TERRA. To verify that HAC-telRNA is
transcribed by Pol II, we treated HAC#21-HeLa cells for various
times with the Pol II inhibitor a-amanitin at 20 mg/ml. Total
RNA was extracted for each time interval and transcript levels
were determined by RT-real-time PCR (Fig. 5B). In control
experiments, 18S rRNA, which is transcribed by RNA polymerase
I, was insensitive to the treatment, whereas Pol II-derived GAPDH
transcript levels were reduced in the treated cells, confirming a-
amanitin specificity in this experimental condition. We found that
levels of HAC-telRNA, as well as of TERRA derived from
chromosome Xp-Yp, were dramatically decreased by a 2-hour
treatment with a-amanitin, suggesting that HAC-telRNA is
produced by Pol II. Unexpectedly, however, Xp-Yp-derived
TERRA showed an increase in transcript level at later time points
(4 or 8 hr). This may suggest that TERRA can be synthesized by
polymerase(s) other than Pol II.
To test this possibility, we conducted a similar experiment with
50 mg/ml of a-amanitin for 5 hours (Fig. S3), in which the Ser-2
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phosphorylated form of Pol II (S2P) is largely depleted [34]. In an
immunoblotting experiment using an antibody that recognizes
total Pol II (Fig. S3A upper left, 0 hr), extracts from untreated cells
showed multiple retarded bands with an apparent molecular mass
greater than the largest subunit of Pol II (220 kDa) [27]. Among
them, the intensity of the slowest band (filled circle in Fig. S3A)
was significantly decreased by the 5-hour a-amanitin treatment.
When a parallel blot was probed with the anti-S2P Pol II antibody
(Fig. S3A, right), a band with mobility similar to the slowest band
that was detected with anti-total Pol II almost disappeared in the
Figure 4. The seeded telomere is transcribed. A. RT-PCR analysis of telomere-repeat-containing transcripts. Nuclear RNAs were converted to
cDNA using (CCCTAA)5 oligonucleotide DNA with a 59-end tagging sequence (RT in the lower panel). Unique subtelomeric DNA of HAC#21 (HAC) or
chromosome Xp-Yp (Xp-Yp) was amplified (PCR in the lower panel) in a reverse-transcriptase-dependent manner (RT+). RNA was obtained from HeLa
(HAC#212) or HAC#21-HeLa (HAC#21+) cells. B. 59-RACE of telomere transcripts in HAC#21-HeLa and HAC#21-NIH-3T3 cells. cDNA was produced
using a reverse-transcription primer specific to the targeting vector. The PCR product is indicated by an arrowhead in the upper panel. The positions
of the primer and deduced transcription start site are indicated in the lower panel by an arrow and a blue circle, respectively. C. Sequence analysis of
PCR products in B (arrowhead). Two TSS’s (positions labeled by blue circles) were identified for HAC-telRNA. A TATA-like sequence was found
immediately upstream of the TSS’s (highlighted by red letters). D. Pol II occupancies of the seeded subtelomere determined by ChIP. Antibodies
specific to either phosphorylated serine-2 or serine-5 on the C-terminus heptad repeats of the largest subunit of Pol II (S2P and S5P, respectively), and
to total Pol II (total) were used. Enrichment of each type of Pol II at the seeded subtelomere (x, y, and w; w is a region 0.2 kb upstream of the TSS’s) as
well as at the TSS of the c-actin gene (ACTG1) was measured. Bars indicate s.d. of three independent ChIP experiments. The relative positions of PCR
regions and TSS’s (blue circle) are shown in the left panel.
doi:10.1371/journal.pone.0088530.g004
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Figure 5. The telomeric transcript from HAC#21, HAC-telRNA, is an unusual Pol II transcript. A. Splicing of HAC-telRNA examined by RT-
PCR. (Top) exon and intron sequences of two variant transcripts are shown (exons in shade) with highlighting of the intron donor and acceptor
consensus sequences in red. Primer Q spans the splice junction of two exons (broken line). Primer T ends with CGG-39, which anneals with the last
three nucleotides (GCC-39, blue underlines)) of both variant exons. (Bottom left) HAC-telRNA variant 1 was detected using variant 1-specific primers
(primers Q+R). P, parental line.#5,#22, and#1 are independent HAC#21-containing clones. (Bottom right) RT-PCR products generated by primers S
and T. The two variants gave rise to two PCR products with or without the terminal 26-nt sequence of the first exon. P, parental cells; and #1, a
HAC#21-HeLa clone. B. Pol II-dependent transcription of HAC-telRNA. HAC#21-HeLa cells were treated with 20 mg/ml of a-amanitin for the indicated
times. Transcript levels at each time point determined by real-time PCR are shown relative to the non-treated condition (top panel), or after
normalization to 18S rRNA levels (bottom panel). The half-life of HAC-telRNA was estimated from the intersection of an exponential regression curve
with the half value (dotted line). Bars indicate s.e.m. of three independent quantifications. C. Polyadenylation of transcripts. An aliquot of total RNA
was affinity purified with an oligo-dT column. Various amounts of the poly(A)-enriched RNAs were mixed with the total RNA at the indicated ratios,
and test RNAs present in the mixture were detected by real-time RT-PCR. cDNA was generated using a mixture of gene-specific primers. D. Northern
blot hybridization of HAC-telRNA. Total RNA was obtained from HeLa and HAC#21-HeLa cells, and was subjected to avidin-bead affinity purification
with biotinylated oligo DNA containing (CCCTAA)5 repeats. Bound RNAs were detected with a targeting-vector-specific probe (black bar in bottom).
Bracket, concentrated signals in the detected profile.
doi:10.1371/journal.pone.0088530.g005
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treated cells (5 hr). These results imply that the slowest band
represents the S2P form of Pol II. a-amanitin treatment reduced
the amount of S2P Pol II, suggesting that it inhibited the Pol II-
dependent transcription. Taken together, we found that 50 mg/ml
a-amanitin treatment eliminated Ser-2 phosphorylated Pol II.
We again analyzed transcript levels by RT-real-time PCR in
extracts of cells treated with 20 or 50 mg/ml a-amanitin for 5 hrs
(Fig. S3B), and confirmed that 18S rRNA levels were unchanged,
but c-myc levels were reduced in the a-amanitin treated cells (Fig.
S3B, left panel), as expected. To normalize the data obtained
under different conditions, we plotted test RNA levels relative to
18S rRNA levels respectively (Fig. S3B, right panel. The non-
treatment condition is set to one). The c-myc transcript was hardly
detectable at either 20 or 50 mg/ml a-amanitin, consistent with a
rapid turnover rate of c-myc Pol II transcript, with a half-life of less
than one hour [35]. These results indicate that Pol II transcription
was specifically and effectively inhibited by the a-amanitin
treatment, in agreement with the finding that wild-type Pol II is
inactivated in the presence of 3 mg/ml a-amanitin in CHO cells
[36]. TERRA derived from chromosome 15q showed a several-
fold increase in abundance at the 5-hour time point, whereas Xp-
Yp-derived TERRA showed a moderate increase with both drug
concentrations, confirming that TERRA accumulates even when
Pol II elongation (as judged by Ser-2 phosphorylation of Pol II) is
undetectable (Fig. S3A and S3B).
To lend support to the idea that the increased levels of TERRA
that we observed in the presence of a-amanitin resulted from
transcriptional activity, we treated cells with Actinomycin D
(ActD) (Fig. S3C), which inactivates all three RNA polymerases.
We considered the GAPDH transcript as a bona fide marker for
gradual decay upon transcription inhibition (Fig. 5B), and
therefore plotted Xp-Yp TERRA levels relative to GAPDH
transcript levels (Fig. S3C). Xp-Yp TERRA showed a steady,
exponential mode of decay. Given the slower loss of the GAPDH
transcript upon transcriptional inhibition, a half-life of around
4 hrs for Xp-Yp TERRA was estimated; this is an overestimate
because we assumed little change in GAPDH transcript levels in
this time frame. These results suggest that the increased amounts
of TERRA at later time points in the a-amanitin-treated cells did
not result from indirect effects, such as release of TERRA from
RNA transcript degradation cycles. Rather, the increase is likely
attributable to Pol II-independent TERRA transcription. The
notion proposed here that TERRA can be synthesized by
polymerase(s) other than Pol II has been already suggested from
a previous finding that the half-life of TERRA is significantly
shorter when measured in ActD-treated cells than in a-amanitin-
treated cells [12]. Even if TERRA is transcribed by a non-Pol II
RNAP, this seems to occur transiently, as levels of Xp-Yp TERRA
were eventually reduced in a-amanitin-treated cells (Fig. 5B, 12-
hour). By contrast, Pol II-independent (a-amanitin-resistant)
transcription of HAC-telRNA was not observed (Fig. 5B).
A short half-life (as measured with ActD) is a characteristic of
TERRA [11,15]. From the graphs showing relative RNA levels
after the a-amanitin treatment, which were normalized to the
drug-insensitive 18S rRNA levels (Fig. 5B, bottom panel), the half-
life in HAC#21-HeLa cells was estimated to be approximately
4 hrs for HAC-telRNA, 12 hrs for the GAPDH transcript, and
intermediate for Xp-Yp-derived TERRA, respectively. The longer
half-life estimated for Xp-Yp TERRA in the a-amanitin
experiment than in the above experiment (ActD-treatment)
implies Pol II-independent accumulation of a subset of Xp-Yp
TERRA. This result, together with the relatively short half-life,
suggests that levels of HAC-telRNA are tightly regulated, as
reported for TERRA, and as shown for Xp-Yp-derived TERRA
in Fig. S3C.
To analyze whether HAC-telRNA is polyadenylated or not, we
prepared poly(A)-enriched RNA using oligo-dT chromatography.
Target RNAs were amplified in RT-real-time PCR experiments
with gene-specific RT primers for input total RNA and poly(A)-
enriched RNA templates. We compared the relative yield of the
products obtained from each of the two templates (Fig. S4). The
amount of template poly(A)-enriched RNA was adjusted to
represent an equivalent amount of the total RNA template. For
example, if a test RNA had both non-polyadenylated and
polyadenylated forms, it would be detected in the poly(A)-enriched
fraction, to a degree reflecting the fraction of the test RNA
molecules possessing a poly(A) tail. GAPDH transcripts were
detected in the poly(A)-enriched RNA fraction whereas U1
snRNA was not, as expected from the fact that they possess and
lack a poly(A) tail, respectively. We found that HAC-telRNA was
present in the poly(A)-enriched RNA fraction, and therefore
conclude that at least some HAC-telRNA is polyadenylated. It has
been reported that only a small fraction of Xp-Yp TERRA is
polyadenylated [37]. HAC-telRNA was detected in poly(A)-
enriched RNA at a level similar to that of Xp-Yp TERRA (Fig.
S4). Our observation of comparable degrees of enrichment of
HAC-telRNA and Xp-Yp TERRA in the poly(A) RNA pool
suggests that only a small fraction of HAC-telRNA is polyadenyl-
ated.
Nevertheless, the amount of RT-PCR products was larger for
the poly(A)-enriched RNA than for the total RNA, raising the
possibility that the relative amounts of RT-PCR products in Fig.
S4 did not tell the relative population of the polyadenylated test
RNA among the total test RNA. To circumvent this problem, in
Fig. 5C, we performed RT-real-time PCR using total RNA alone,
or mixtures of total RNA plus either 0.1256, 0.56 or 16equiv-
alent poly(A)-enriched RNA (16equivalent poly(A)-enriched RNA
corresponded to the amount of poly(A)-enriched RNA obtained
from the total RNA tested in this experiment). The parallel
reactions were run in identical reaction volumes, and the RT-real-
time PCR yields were compared between the total RNA-only and
the mixed samples (Fig. 5C). We reasoned that if all of the test
RNA was polyadenylated and the poly(A)-enriched RNA was
100% polyadenylated, the RT-PCR yield would be accordingly
increased for the mixed RNA compared to the total RNA alone.
Alternatively, if the test RNA was not polyadenylated at all, the
RT-PCR yields would be the same. For both the GAPDH, and
NEAT1 transcripts (NEAT1 is a non-coding RNA that undergoes
polyadenylation), the mixed samples yielded significantly increased
RT-PCR products compared to the total RNA alone sample, in
proportion to the added poly(A)-enriched RNA, suggesting that
both GAPDH mRNA and NEAT1 RNA are rigorously polyade-
nylated, as expected. In contrast, as for U1 snRNA and Xp-Yp-
derived TERRA, addition of poly(A)-enriched RNA did not
increase the RT-PCR yields in a dose-dependent manner,
indicating that small fractions, if any, of U1 snRNA and Xp-Yp
TERRA are polyadenylated. We found that the amount of RT-
PCR products derived from HAC-telRNA did not increase when
poly(A)-enriched RNA was mixed with the total RNA sample
(Fig. 5C), suggesting that the polyadenylated HAC-telRNA, if any,
is not abundant. Together with the results suggesting that some
HAC-telRNA is polyadenylated (Fig. S4, which used poly(A)-
enriched RNA alone as a template, and thus is likely more
sensitive than Fig. 5C), we conclude that HAC-telRNA is
inefficiently polyadenylated, as is the case for TERRA [15].
To estimate the total length of HAC-telRNA, we performed a
Northern blot (Fig. 5D). Total RNAs were prepared from HeLa
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cells and HAC#21-HeLa cells, and separately incubated with the
CCCTAA primer conjugated with biotin. The oligonucleotide
along with any associated material, including telomeric repeat-
containing RNA, was purified with avidin beads, denatured and
analyzed by Northern blotting. A targeting vector-specific probe,
which corresponds to the entire backbone sequence of the
targeting vector (Fig. 5D, bottom, shown as a black bar), produced
a smeared signal ranging from 0.9 to 6.7 kb in HAC#21-HeLa
cells, but not in HeLa cells (Fig. 5D). Because the length of the
subtelomeric region contained in the spliced HAC-telRNA is
1.8 kb, we estimated that HAC-telRNA contains a few kb of
telomere repeats with an upper length limit of 3.9 kb. This
suggests that a substantial part of the HAC#21 telomere repeat
DNA is transcribed in HAC#21-HeLa cells (the estimated total
length of the telomere repeats in the seeded telomere was 0.5 to
5.5 kb in HAC#21-HeLa cells, as described above). This result is
in agreement with the observation that at least some native human
telomere repeat DNA, up to several kb, is transcribed in TERRA
[13]. To extract HAC#21-specific signals from the smeared signal
observed with HAC#21-HeLa cells, we first measured the
hybridization signals in HeLa cells, and subtracted the density
from signals in HAC#21-HeLa cells. The resulting HAC#21-
specific signals are shown in Fig. S5. To deduce the median length
of HAC-telRNA, we conducted densitometric analysis. We
divided the signal area bounded by the graph in Fig. S5 as
consecutive columns with a single pixel width, and approximated
their sum as the integral of the graph. The line at the median x
divides the region bounded by the graph into equal halves (red line
in Fig. S5). The median length of HAC-telRNA is thus
approximately 3.1 kb, including 1.3 kb (3.1 kb minus 1.8 kb
RNA derived from the subtelomere) of telomere repeats, with the
assumption that HAC-telRNA is spliced. Interestingly, we noticed
an aggregated subpopulation around 2 kb both in the original
Northern blot of HAC#21-HeLa (Fig. 5D, bracket) and the
subtracted image (Fig. S5, bracket). As the graph shape was
asymmetric, revealing more products with lower mobilities, it is
possible that transcription into the telomere DNA tends to
terminate, or that HAC-telRNA is processed. In summary,
HAC-telRNA contains UUAGGG-repeats and shows similar
characteristics with TERRA.
HAC-telRNA is largely chromatin-associated and its total
amount increases moderately upon TRF1 knockdown
To characterize the cellular localization of HAC-telRNA, we
fractionated extracts from HAC#21-HeLa cells into cytoplasmic
(Cyt), nucleoplasmic (NP), and chromatin-bound (Chr) fractions as
previously reported [15]. An immunoblot showed that GAPDH,
nuclear hnRNP A1 and chromatin-bound histone H2B were
highly enriched in the Cyt and NP fractions, NP fraction and the
Chr fraction, respectively, as expected (Fig. 6A). Tubulin was
barely detected in the Cyt but was abundant in the NP fraction,
probably due to polymerization of tubulin rather than incomplete
extraction of the cytoplasm in our experiment. Nucleolin, which is
involved in ribosome biogenesis and is typically found in both the
nucleolus and the nucleus, was detected in the Chr as well as in the
NP fraction. To examine whether RNAs contained in the
nucleoplasm or chromatin were separated by the fractionation,
test RNA present in each fraction was analyzed by RT-real-time
PCR using specific primers. GAPDH transcripts and NEAT1 RNA,
which constitutes nuclear bodies called paraspeckles [38], were
largely fractionated in the NP and Chr fractions, whereas U1 and
XIST RNAs were enriched in the Chr fraction, as expected
(Fig. 6B). In contrast, Xp-Yp-derived TERRA was detected in the
Chr and NP fractions, as reported previously [15]. We found that
HAC-telRNA (detected with primers that recognized both spliced
and unspliced HAC-telRNA; PCR in Fig. 4A) was also enriched in
the Chr and NP fractions (Fig. 6B), suggesting that HAC-telRNA
localizes to chromatin similarly to endogenous TERRA [11].
Interestingly, we observed that spliced HAC-telRNA (variant 1)
was enriched in the Chr fraction to a greater extent than the total
HAC-telRNA. Taken together, HAC-telRNA is largely bound to
chromatin, suggesting that it functions as a non-coding RNA at the
telomere.
In order to examine a possible role of telomeric proteins in the
regulation of HAC-telRNA, we depleted TRF1 by siRNA and
examined RNA levels two days after the transfection (Fig. 6C and
6D). The TRF1 mRNA level was reduced to approximately 20%
of the control cells, while that of GAPDH mRNA was unchanged,
(Fig. 6C). By contrast, the abundance of HAC-telRNA, as well as
endogenous TERRA derived from Xp-Yp and 15q, was
moderately increased (Fig. 6D). Interestingly, expression of the
puromycin resistance gene encoded by the seeded vector was also
elevated. This trend was also observed for endogenous subtelo-
meric transcripts of WASH, which are transcribed from 4–6 kb
proximal sites to telomere repeats in several chromosomes [39].
These results suggest that telomeric and subtelomeric transcription
was derepressed when TRF1 was depleted. Collectively, we have
shown that the seeded telomere in HAC#21-HeLa cells encodes a
transcript that is biochemically similar to the endogenous
chromosome-derived TERRA.
Discussion
We have developed a mini-chromosome HAC#21 that is useful
for analyzing the behavior of a single telomere in mammalian cells.
The HAC#21 telomere was stably maintained during six weeks in
HeLa cells (Fig. S1A), indicating its functional proficiency as a
telomere. We have revealed that the telomere region on HAC#21
is replicated during mid-S phase in HeLa cells, that the telomere-
binding proteins associate with subtelomeric regions up to 0.7-kb
proximal to the telomere repeats, and that a TERRA-like non-
coding RNA is transcribed from the HAC#21 subtelomere and
telomere in both human and mouse cells.
HAC#21 as a molecular tool to analyze the behavior of
mammalian telomeres
HAC#21 was stable as a mini-chromosome and maintained the
seeded subtelomere DNA at the chromosome end (Fig. 1).
Knowing the precise nucleotide sequences of the seeded sub-
telomere, we were able to design primers and probes in
experiments to analyze the behavior of the seeded telomere.
The seeded telomeres in HeLa and NIH-3T3 cells maintained
their relative lengths, which were comparable to the endogenous
telomeres of the host cells, suggesting that the seeded telomeres are
under the control of the respective host cell’s telomere mainte-
nance program. A similar approach was taken to analyze telomere
silencing in mouse cells [40]. Because the native telomere consists
of chromatin encompassing both the telomere repeat DNA array
and repetitive and polymorphic subtelomere DNAs, it is difficult to
pinpoint the cis DNA element responsible for a telomere function
of interest. The HAC technology affords an opportunity to analyze
a series of telomeres composed of defined DNA sequences. In this
study, we have found that an ectopic DNA region neighboring the
HAC telomere repeats is transcribed. This result raises an
interesting possibility that the telomere repeat DNA array per se
may induce transcription of its upstream region, which should be
tested in the future. Therefore, the current study reemphasizes the
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usefulness of the HAC in precisely analyzing the metabolism of a
single telomere in mammalian cells.
Replication timing of the seeded subtelomere on
HAC#21 appears to be determined by the proximal
native DNA of Chr21 in HeLa cells
Previous studies revealed that replication of human telomeres
occur with timings specific to individual telomeres [6,8–10]. Our
results that the seeded telomere on HAC#21 replicates in mid-S
phase in HAC#21-HeLa cells are consistent with these observa-
tions (Fig. 2).
There are few, if any, active replication origins within the
telomere repeats, and telomere replication is achieved in most
cases by replication forks that have fired at replication origins
within the subtelomere [41]. In fiber-FISH experiments it was
suggested that in human cells the replication fork, most often
originating within 200 kb of chromosome ends, progresses towards
telomeres at a uniform speed, and ultimately reaches telomere
repeats [42].
We found that the seeded subtelomere was synchronously
replicated at mid-S phase in HeLa cells (Fig. 2), similar to the
targeting region in cells lacking HAC#21 (Fig. S6). Thus, the
same set of origins positioned proximal to the targeted region in
hChr21 fire with the same replication timing in the context of both
hChr21 and HAC#21 to replicate neighboring regions. In the
future, it is necessary to address the question whether the
synchronous replication timing is attributed to re-setting of origin
Figure 6. HAC-telRNA is a chromatin-associated transcript. A. Immunoblot analyses were performed for the indicated proteins to verify the
efficiency of the subcellular fractionation. Cyt, cytoplasmic; NP, nucleoplasmic; Chr, chromatin. One representative result is shown. Similar results were
obtained for all proteins samples used for the experiment. B. Subcellular localization of transcripts. RNAs were purified from each subcellular fraction,
and the abundance of a test RNA was quantified by RT-real-time PCR. The relative abundance in each fraction is shown. Xp-Yp, Chr Xp-Yp-derived
TERRA. Bars indicate s.e.m. from three independent experiments. The relative abundance of HAC-telRNA splice variant 1 (HAC (variant 1)) in the
chromatin fraction was significantly larger than that of total HAC-telRNA (HAC) (asterisk, one-tailed Student’s t-test). C. Transcript levels of indicated
genes in TRF1-knockdown HAC#21-HeLa cells. Total RNAs extracted from cells at 48 hrs post-transfection were examined in triplicate by RT-PCR. A
representative result is shown. D. TRF1-knockdown effect. Amounts of RT-PCR products obtained from control knockdown (siCtrl) and TRF1-
knockdown (siTRF1) HAC#21-HeLa cells were quantified from SYBR Gold-stained gels. 18S rRNA served as an internal control of three independent
knockdown experiments. Bars, s.e.m. from three independent knockdown experiments.
doi:10.1371/journal.pone.0088530.g006
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firing timings by integration of telomere repeats or just a property
inherent to this specific integrated region of hChr21.
Binding of telomere proteins decreases rapidly with
distance from the telomere repeats on the HAC#21
seeded telomere in HeLa cells
In HAC#21-HeLa cells, we found that telomeric proteins were
distributed to a modest extent along HAC#21 subtelomeric DNA
proximal to the region 0.7-kb from the telomere repeats, but not at
all in the region 3.5-kb from the telomere repeats (Fig. 3). This
result in HAC#21 corroborates recent observations of native
ChrXq-Yq in human HTC116 and U2OS cells [14]. Taken
together, telomeric proteins TRF1 and TRF2 spread up to one kb
in human subtelomeres. Because the spreading occurs to a similar
degree in different sequence contexts of subtelomeres, native or
seeded, it is likely based on cis-acting mechanisms. This contrasts
with the fission yeast, in which telomere proteins can spread up to
several-kb from internal sites and commit the region to hetero-
chromatin [43], suggesting that the spreading mechanism is
functionally distinct between fission yeast and mammals.
TERRA-related RNA is transcribed from the de novo
HAC#21 telomere in mammalian cells
In agreement with the notion that transcription through
telomere DNA and/or the resulting TERRA transcript is
necessary for telomeres [17,18], we found that telomere DNA is
transcribed by Pol II from a specific site downstream of a TATA-
like sequence in the telomere-associated region in HAC#21,
namely, the integrated vector sequence DNA. The resulting
TERRA-like transcript, HAC-telRNA, shares similarity with
TERRA: first, it is a chromatin-associated Pol II transcript that
largely lacks a poly(A) tail and so is unstable (Fig. 5B, 5C and 6B).
Second, its transcription start site resides in a similar chromosomal
context, a few kb upstream of the telomere repeats (Fig. 4C). These
results suggest a hypothesis that local telomere chromatin factors
lead to transcription of HAC-telRNA in HAC#21. On the other
hand, generation of HAC-telRNA appears to exclusively depend
on Pol II (Fig. 5B), possibly reflecting promoter architecture
different from that of Xp-Yp-derived TERRA.
It is believed that some TERRA have a specific CpG promoter
called 61-29-37 repeats [13]. In line with a possibility that cryptic
TERRA promoters specified telomere-associated transcription in
HAC#21, we searched for transcription factor binding motifs
shared between a region6500 bp from the TSS for HAC-telRNA
and the 61-29-37 repeats (the sequence included in a subtelomeric
element called TelBam3.4 [44]). A public program for promoter
searches, Proscan ver. 1.7 (http://www-bimas.cit.nih.gov/cgi-bin/
molbio/proscan), identified Sp1 and CREB as candidate tran-
scription factors, and a cis-element JCV-repeat was predicted in
common with the 61-29-37 repeats. In contrast, the 61-29-37
repeats seemed TATA-less. Considering that half of all TERRA
species including Xp-Yp TERRA are generated without the
predictable 61-29-37 repeats, it is quite likely that heterologous
mechanisms specify transcription of the TERRA family of RNAs,
including HAC-telRNA.
There is a discrepancy concerning how the more distal telomere
repeats are transcribed into TERRA. This is important because
TERRA-bound proteins are involved in G-tail function related to
end-protection [18]. In one report, because TERRA contains the
UUAGGG tract length of 200 nt as revealed by reverse-
transcription primer extension, the depth of transcription into
telomere repeat DNA appears quite small compared to the several
kb or more of human telomere DNA tracts [15]. In another,
TERRA-specific UUAGGG tracts were up to several kb when
determined by Northern blotting [13]. The larger estimate is
supported by the observation that in cells over-expressing
telomerase, TERRA gradually becomes elongated as the template
telomere DNA is further lengthened [45]. Here, because we know
the precise nucleotide length from HAC-telRNA to pure
TTAGGG repeats in HAC#21, our Northern experiments
demonstrate that transcription, once started, does proceed into a
substantial stretch of telomere repeats (Fig. 5D).
Another novel aspect of HAC-telRNA is that it is spliced,
probably at telomere chromatin. Although it is unknown whether
TERRA undergoes splicing, splicing-factors were indeed detected
at telomeres by mass spectrometry analyses [46,47]. Their roles at
telomeres will be addressed in the future.
Reports on regulation of TERRA by shelterin components are
conflicting. It was at first addressed under the hypothesis that
TERRA is a telomerase inhibitor, thereby impacting telomere
length; the reportedly decreased TERRA levels upon TRF1-
knockdown implied it as an effector of telomere-bound TRF1, a
cis-acting indirect inhibitor of telomerase, in mouse cells [12].
However, no apparent effect on TERRA levels was found in cells
conditionally knocked-out for TRF1 [41], suggesting that TRF1
itself is not a direct regulator of TERRA. However, we found that
depletion of TRF1 via siRNA led to increased expression of
different classes of RNA: telomere-related non-coding RNA
(TERRA and HAC-telRNA) and subtelomeric protein-coding
transcripts (WASH and puromycin-resistance genes) (Fig. 6C and
6D). Since the TSS’s of the two types of transcripts are located
similarly several-kb apart from telomere repeats, and since
TERRA expression is epigenetically regulated [12,48], a scenario
can be posited in which TRF1 affects TERRA status via
epigenetic repression of transcription. Our result (day 2 after
siRNA treatment) can be interpreted as an early response of
telomeres to TRF1-depletion before it is translated into length
homeostasis (i.e., to be elongated), tempting us to speculate that
TERRA is a conserved regulator of telomerase [49].
Collectively, our study indicates that HAC is a useful tool to
study the behavior of an individual telomere in mammalian cells.
Further studies using the system will provide insights into telomere
biology in humans.
Supporting Information
Figure S1 HAC#21 in HeLa and NIH-3T3 cells. A. Copy
number of HAC#21 retained in HeLa cells. Interphase cells were
hybridized with the alphoid probe specific to hChr21 and hChr13,
and the number of nuclear dot signals was counted. +puro and -
puro indicate the cells cultured for 6 weeks with or without
puromycin, respectively. B. The targeting vector was detected with
a hChr21-specific probe (21a, 7.5 kb) and the vector-specific probe
(puro, 6.3 kb). Locations of the probes used in this experiment are
shown above. Southern blot hybridization using the two probes is
shown below. HeLa, parental HeLa cells, and clone#1, one of the
independent HAC#21-HeLa clones. Arrow indicates the 7.5-kb
band specifically detected in HAC#21-HeLa cells. C. Bulk
telomere DNA lengths in HeLa and NIH-3T3 cells were detected
by Southern hybridization using the (CCCTAA)4 probe. Exper-
iments were performed with duplicate samples (a and b). P,
parental. #4 and #22, two independent HAC#21-NIH-3T3
clones.
(EPS)
Figure S2 Specificity of anti-TRF1, TPP1, and TRF2
antibodies. A. Whole cell extracts from HeLa or NIH-3T3 were
immunoblotted with the indicated antibodies used in Fig. 3.
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Arrowheads indicate bands expected from the mobility of cognate
proteins. B. Sonicated DNAs were de-crosslinked, purified and
separated on agarose gel, followed by EtBr staining.
(EPS)
Figure S3 Effects of RNA polymerase inhibition on
TERRA transcript levels. A. HAC#21-HeLa cells were
treated with or without 50 mg/ml of a-amanitin for 5 hrs. Whole
cell lysates obtained from untreated (a-amanitin 0 hr) or treated
cells (5 hr) were immunoblotted with Pol II-specific antibodies.
The uppermost band in the left panel (filled circle) showed lower
intensity after treatment with a-amanitin, compared to the
untreated cells. This band was positive with the anti-S2P Pol II
antibody (right panel). Histone H2B served as a loading control. B.
HAC#21-HeLa cells were treated with a-amanitin for 5 hrs at a
concentration of 0, 20, or 50 mg/ml. Total RNAs were extracted
from the cells and transcript levels were analyzed by RT-real-time
PCR. (Left) Transcript levels are shown, with those of non-treated
cells set to one. (Right) Transcript levels relative to those of 18S
rRNA are shown. The values for the lanes indicated by asterisks
are as follows. *, 0.00029, 0.097, 0.025 and 0.021 (left to right);
and **, 0.047, 0.015 (left to right). C. HAC#21-HeLa cells were
treated with 5 mg/ml actinomycin D up to 8 hrs. Transcript levels
of Xp-Yp TERRA and GAPDH were determined by RT-real-time
PCR. Levels of Xp-Yp TERRA were normalized to those of
GAPDH transcripts at each time point (y-axis in log scale). Half-life
for Xp-Yp TERRA is estimated to be about 4 hours (dotted line),
given a negligible decrease in GAPDH transcript levels during the
experimental time-scale.
(EPS)
Figure S4 Polyadenylation of HAC-telRNA. Two equal
aliquots of total RNA were subjected to RT-real-time PCR
analysis, one of which was processed in advance for poly(A)-
enrichment by using the oligo-dT column (poly(A)-enriched). The
amounts of test RNAs determined by real-time interpolation were
plotted as a relative ratio to those in the unprocessed aliquot of
total RNA (input total RNA). Bars indicate s.d. of three
independent poly(A)-purification experiments. The value of the
lane indicated by an asterisk is 0.0010.
(EPS)
Figure S5 HAC#21-specific Northern blot hybridiza-
tion signals. The signal intensity in Northern blot hybridization
(Fig. 5D) was measured along each lane with a densitometer.
Signal intensities in the HeLa lane were subtracted from those in
the HAC#21-HeLa lane side by side, to extract HAC#21-specific
hybridization signals. The resulting density profile was plotted
along the distance from the top of the membrane. The median
length of HAC-telRNA estimated from the signal profile is
indicated by the vertical red line. The bracket indicates a
noticeable aggregate of signals corresponding to a transcript
length ranging from 2 to 3 kb.
(EPS)
Figure S6 BrdU incorporation of Chr21 in S phase in
HeLa cells. A. FACS profile of DNA content in HeLa cells
released from a double thymidine-aphidicolin block. B. Cumula-
tive plots of BrdU-incorporated fractions for a test locus for the
indicated hrs, determined as in Fig. 2C. The location of PCR
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